Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership121,052 shares
Latest Disclosed Value $ 16,871,017
Qube Research & Technologies Ltd ownership in GILD / Gilead Sciences, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 121,052 shares of Gilead Sciences, Inc. (CH:GILD) valued at $16,871,017 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,547,038 shares of Gilead Sciences, Inc.. This represents a change in shares of -95.25% during the quarter.

Qube Research & Technologies Ltd has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 65,500 of underlying shares valued at $9,128,735 USD and put options representing 45,200 of underlying shares valued at $6,299,524 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 121,052 -2,425,986 -95.25 16,871 -94.60 0.0188
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,547,038 -2,281,513 -47.25 312,623 -41.67 0.3176
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 4,828,551 69,976 1.47 535,969 1.59 0.5538
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 4,758,575 2,401,289 101.87 527,583 99.74 0.5361
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,357,286 2,357,286 264,134 0.3064
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 0 -1,509,613 -100.00 0 -100.00
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 1,509,613 -703,042 -31.77 103,575 -36.10 0.1637
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 2,212,655 1,508,607 214.28 162,077 184.17 0.2570
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 704,048 -446,276 -38.80 57,035 -33.84 0.1110
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,150,324 428,583 59.38 86,205 54.98 0.2252
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 721,741 505,201 233.31 55,625 209.61 0.2022
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 216,540 216,540 17,966 0.0773
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 0 -971,154 -100.00 0 -100.00
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 971,154 299,321 44.55 59,910 44.27 0.3568
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 671,833 99,164 17.32 41,526 21.97 0.3063
2022-05-09 2022-03-31 13F GILEAD SCIENCES COM 375558103 572,669 -240,073 -29.54 34,045 -42.31 0.2885
2022-02-10 2021-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 812,742 761,375 1,482.23 59,013 1,544.73 0.4555
2022-02-01 2021-12-31 13F GILEAD SCIENCES COM 375558103 812,742 761,375 59,013 0.4560
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 51,367 -3,641 -6.62 3,588 -5.28 0.0450
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 55,008 -38,801 -41.36 3,788 -37.52 0.0432
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 93,809 68,042 264.07 6,063 303.93 0.0961
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 25,767 -396,671 -93.90 1,501 -94.38 0.0213
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 422,438 422,438 26,694 0.3810
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 0 -52,287 -100.00 0 -100.00
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 52,287 8,259 18.76 3,909 36.63 0.1606
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 44,028 27,122 160.43 2,861 166.88 0.0898
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 16,906 -14,719 -46.54 1,072 -49.84 0.7140
2019-08-02 2019-06-30 13F GILEAD SCIENCES COM 375558103 31,625 -1,155 -3.52 2,137 0.28 0.5088
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 32,780 32,780 2,131 0.2814
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 0 -36,604 -100.00 0 -100.00
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 36,604 27,826 317.00 2,826 354.34 0.3757
2018-08-15 2018-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 8,778 -4 -0.05 622 -6.04 0.3925
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 8,778 -4 622
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 8,782 8,782 662 0.2545
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM Call 65,500 -8.26 9,129 4.17 n/a n/a n/a
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM Call 71,400 20.81 8,764 33.58 n/a n/a n/a
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM Call 59,100 -42.79 6,560 -42.72 n/a n/a n/a
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM Call 103,300 19.28 11,453 18.03 n/a n/a n/a
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM Call 86,600 497.24 9,704 624.65 n/a n/a n/a
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM Call 14,500 -42.69 1,339 -36.87 n/a n/a n/a
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM Call 25,300 -53.83 2,121 -43.58 n/a n/a n/a
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM Call 54,800 3,760 n/a n/a n/a
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM Call 12,400 -70.55 1,005 -68.17 n/a n/a n/a
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM Call 42,100 13,933.33 3,155 13,613.04 n/a n/a n/a
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM Call 300 23 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM Put 45,200 -15.51 6,300 -4.07 n/a n/a n/a
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM Put 53,500 59.23 6,567 76.08 n/a n/a n/a
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM Put 33,600 -87.67 3,730 -87.65 n/a n/a n/a
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM Put 272,400 -79.35 30,201 -79.57 n/a n/a n/a
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM Put 1,319,400 3,514.79 147,839 4,285.58 n/a n/a n/a
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM Put 36,500 7.99 3,372 18.99 n/a n/a n/a
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM Put 33,800 -92.64 2,834 -91.01 n/a n/a n/a
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM Put 459,500 291.40 31,526 266.62 n/a n/a n/a
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM Put 117,400 -50.57 8,600 -55.30 n/a n/a n/a
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM Put 237,500 34.56 19,240 45.46 n/a n/a n/a
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM Put 176,500 27.44 13,227 23.91 n/a n/a n/a
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM Put 138,500 10,674 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.